ArticleJournal of the American Heart Association2021
Long-Term Outcomes of Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease.
Article in Journal of the American Heart Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 23 citations in OpenAlex.
- Transaortic TAVR and MICS-CABG in a Patient on Dialysis With RCA Restenosis.JACC. Case reports · 2026Article
- Prognostic impact of severe malnutrition in dialysis patients who underwent transcatheter aortic valve replacement.Cardiovascular intervention and therapeutics · 2026Article
- Long-term outcomes of patients receiving Dialysis and undergoing Transcatheter aortic valve replacement with contemporary balloon-expandable valves.International journal of cardiology. Heart & vasculature · 2026Article
- Steady-state regional cerebral oxygen saturation integrates multidimensional periprocedural factors and predicts long-term mortality after transcatheter aortic valve implantation.Journal of anesthesia · 2026Article
- Impact of Improved End-Stage Renal Disease Patient Survival on Prosthetic Valve Selection in Aortic Valve Replacement: A Nationwide Cohort Analysis.Journal of clinical medicine · 2026Article
- Transcatheter Aortic Valve Replacement in Special Population Groups.Reviews in cardiovascular medicine · 2025Review
- Imaging characteristics and clinical outcomes of hemodialysis vs. non-hemodialysis patients undergoing transcatheter aortic valve replacement: a Japanese single-center experience.Heart and vessels · 2025Article
- Diabetes and calcific aortic valve disease: controversy of clinical outcomes in diabetes after aortic valve replacement.Frontiers in endocrinology · 2025Review
- Transfemoral Compared to Transapical Transcatheter Aortic Valve Implantation in Chronic Dialysis-Dependent Patients.Journal of clinical medicine · 2024Article
- Descriptive analysis of long-term survival after aortic valve replacement for dialysis patients: importance of renal pathologies and age.General thoracic and cardiovascular surgery · 2024Article
- Obesity and Transcatheter Aortic Valve Replacement.Journal of cardiovascular development and disease · 2024Review
- Transcatheter aortic valve replacement in patients with chronic kidney disease: a multi-centre retrospective study.Annals of medicine and surgery (2012) · 2024Article
- In-hospital outcomes of transcatheter aortic valve replacement in patients with chronic and end-stage renal disease: a nationwide database study.BMC cardiovascular disorders · 2024Article
- Racial disparities in TAVR outcomes in patients with cancer.Frontiers in cardiovascular medicine · 2024Article
- Valvular heart disease in patients on kidney replacement therapy: "opening Pandora's box".Clinical kidney journal · 2023Article
- Transcatheter Aortic Valve Replacement: Not for Everyone Yet?JACC. Advances · 2023Article
- Article
- Long-Term Outcomes of Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease.Journal of the American Heart Association · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Aortic stenosis is prevalent in end-stage renal disease. Transcatheter aortic valve replacement (TAVR) is a plausible alternative for surgical aortic valve replacement. However, little is known regarding long-term outcomes in patients with end-stage renal disease who undergo TAVR. Methods and Results We identified all patients with end-stage renal disease who underwent TAVR from 2011 through 2016 using the United States Renal Data System. The primary end point was 5-year mortality after TAVR. Factors associated with 1- and 5-year mortality were analyzed. A total of 3883 TAVRs were performed for patients with end-stage renal disease. Mortality was 5.8%, 43.7%, and 88.8% at 30 days, 1 year, and 5 years, respectively. Case volumes increased rapidly from 17 in 2011 to 1495 in 2016. Thirty-day mortality demonstrated a dramatic reduction from 11.1% in 2012 to 2.5% in 2016 (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.